Context Therapeutics Inc. (NASDAQ:CNTX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Karen Smith Other companies: Skye Bioscience, Inc. (Director · Since at least Jul 2, 2024); Sangamo Therapeutics, Inc. (Director · Since at least Jun 26, 2018); Aurinia Pharmaceuticals Inc (Director · Aug 18, 2023 – Nov 21, 2024 · Past); Quince Therapeutics, Inc. (Chief Medical Officer · May 19, 2022 – Feb 1, 2023 · Past); Tourmaline Bio Inc. (Director · May 16, 2022 – Jun 13, 2023 · Past); Emergent BioSolutions Inc. (EVP, Chief Medical Officer · May 21, 2020 – May 7, 2021 · Past); Antares Pharma Inc (Director · Mar 1, 2019 – May 24, 2022 · Past); Acceleron Pharma Inc (Director · Nov 15, 2017 – Nov 19, 2021 · Past); Sucampo Pharmaceuticals Inc (Director · Jul 15, 2017 – Feb 13, 2018 · Past); Jazz Pharmaceuticals plc (EVP, R&D and CMO · Apr 13, 2015 – Mar 5, 2018 · Past) | Independent Director · Since at least Sep 4, 2024 |
| Jennifer Evans Stacey Other companies: Neogen Corporation (Chief Legal Officer · Since at least Apr 8, 2026); Galera Therapeutics, Inc. (See Remarks · Oct 8, 2021 – Feb 25, 2023 · Past); Antares Pharma Inc (SVP, General Counsel & Secty · May 29, 2014 – May 28, 2015 · Past); Auxilium Pharmaceuticals Inc (Executive VP & General Counsel · Jun 6, 2006 – Feb 28, 2011 · Past) | Independent Director · Since at least Oct 19, 2021 |
| Luke Walker Other companies: Zentalis Pharmaceuticals, Inc. (Director · Since at least May 24, 2024); Harpoon Therapeutics Inc (Chief Medical Officer · Oct 3, 2022 – Mar 11, 2024 · Past) | Director · Since at least Sep 4, 2024 |
| Linda West Other companies: Galera Therapeutics, Inc. (Director · Mar 31, 2020 – Jul 1, 2023 · Past) | Independent Director · Since at least Oct 19, 2021 |
| Philip W Kantoff Other companies: ESSA Pharma Inc (Director · Sep 13, 2022 – Mar 25, 2024 · Past) | Director · Since at least Oct 19, 2021 |
| Alex Levit | Chief Legal Officer · Since at least Nov 5, 2026 |
| Andy Pasternak | Chairman, Independent Director · Since at least Jan 13, 2025 |
| Christopher Beck | SVP of Operations · Since at least Nov 5, 2026 |
| Curtis Reinard | Director, Clinical Operations · Since at least Nov 5, 2026 |
| Erin Zebrowski | Director, Clinical Sciences · Nov 4, 2026 – Nov 4, 2026 · Past |
| Gregory Moylan | Executive Director, External Manufacturing · Since at least Nov 5, 2026 |
| Indu Ramachandran | Executive Director, Translational Medicine · Since at least Nov 5, 2026 |
| Jennifer Dashnau | SVP Technical Operations · Since at least Nov 5, 2026 |
| Jennifer Minai-Azary | Chief Financial Officer · Since at least Sep 9, 2026 |
| Karen Chagin | Chief Medical Officer · Since at least Jun 9, 2025 |
| Martin Lehr | Chief Executive Officer · Since at least Aug 19, 2022 |
| Mary Sphar | Executive Assistant & Office Manager · Nov 4, 2026 – Nov 4, 2026 · Past |
| Michael Girouard | Executive Director, Quality · Since at least Nov 5, 2026 |
| Philip Kantoff | Independent Director · Since at least Nov 4, 2026 |
| Ullmann Claudio Dansky | Chief Medical Officer · Aug 1, 2024 – Feb 13, 2025 · Past |
| William F Rencher | Head of CMC and Regulatory · Oct 19, 2021 – Oct 19, 2021 · Past |